Last updated: 26 August 2024 at 8:00pm EST

Christopher Yea Net Worth




The estimated Net Worth of Christopher Yea is at least $3.64 Million dollars as of 22 August 2024. Mr. Yea owns over 3,125 units of KalVista Pharmaceuticals Inc stock worth over $938,986 and over the last 8 years he sold KALV stock worth over $1,773,567. In addition, he makes $926,044 as Chief Development Officer at KalVista Pharmaceuticals Inc.

Mr. Yea KALV stock SEC Form 4 insiders trading

Christopher has made over 25 trades of the KalVista Pharmaceuticals Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 3,125 units of KALV stock worth $33,500 on 22 August 2024.

The largest trade he's ever made was selling 39,886 units of KalVista Pharmaceuticals Inc stock on 14 February 2024 worth over $598,689. On average, Christopher trades about 5,735 units every 57 days since 2016. As of 22 August 2024 he still owns at least 87,592 units of KalVista Pharmaceuticals Inc stock.

You can see the complete history of Mr. Yea stock trades at the bottom of the page.





Christopher Yea biography

Christopher M. Yea Ph.D. serves as Chief Development Officer of the Company. He served as the Chief Development Officer of KalVista Limited since November 2015 and became our Chief Development Officer as of November 2016. Prior to joining us, he was the Chief Operating Officer at Vantia, Ltd. from its spin-out from Ferring Pharmaceuticals in 2008, until November 2015. Prior to the spin-out of Vantia, Dr. Yea led the Biology group and was responsible for transition of candidates into development at Ferring Pharmaceuticals. Following post-doctoral work he spent several years at Roussel-UCLAF and Hoechst Marion Roussel. Dr. Yea holds a B.Sc. and a Ph.D. in Biochemistry from the University of Bristol, UK.

What is the salary of Christopher Yea?

As the Chief Development Officer of KalVista Pharmaceuticals Inc, the total compensation of Christopher Yea at KalVista Pharmaceuticals Inc is $926,044. There are 4 executives at KalVista Pharmaceuticals Inc getting paid more, with Thomas Crockett having the highest compensation of $1,731,160.



How old is Christopher Yea?

Christopher Yea is 56, he's been the Chief Development Officer of KalVista Pharmaceuticals Inc since 2016. There are 8 older and 8 younger executives at KalVista Pharmaceuticals Inc. The oldest executive at KalVista Pharmaceuticals Inc is Arnold Oronsky, 80, who is the Independent Director.

What's Christopher Yea's mailing address?

Christopher's mailing address filed with the SEC is C/O KALVISTA PHARMACEUTICALS, INC, 55 CAMBRIDGE PARKWAY, SUITE 901E, CAMBRIDGE, MA, 02142.

Insiders trading at KalVista Pharmaceuticals Inc

Over the last 8 years, insiders at KalVista Pharmaceuticals Inc have traded over $74,823,944 worth of KalVista Pharmaceuticals Inc stock and bought 4,877,063 units worth $58,591,487 . The most active insiders traders include Holdings A/S Novo, Capital Management, L.P.Ra ..., and Rajeev M. Shah. On average, KalVista Pharmaceuticals Inc executives and independent directors trade stock every 19 days with the average trade being worth of $835,088. The most recent stock trade was executed by Benjamin L Palleiko on 6 September 2024, trading 15,625 units of KALV stock currently worth $167,500.



What does KalVista Pharmaceuticals Inc do?

kalvista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors.



What does KalVista Pharmaceuticals Inc's logo look like?

KalVista Pharmaceuticals Inc logo

Complete history of Mr. Yea stock trades at KalVista Pharmaceuticals Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
22 Aug 2024 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Option 3,125 $12.42 $38,813
22 Aug 2024
87,592
17 Aug 2024 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Option 11,495 $12.00 $137,940
17 Aug 2024
91,569
17 May 2024 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Option 18,789 $11.92 $223,965
17 May 2024
91,684
17 Feb 2024 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Option 18,788 $14.86 $279,190
17 Feb 2024
84,948
14 Feb 2024 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Sale 39,886 $15.01 $598,689
14 Feb 2024
66,160
17 Nov 2023 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Option 11,497 $8.12 $93,356
17 Nov 2023
53,159
17 Aug 2023 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Option 11,494 $10.93 $125,629
17 Aug 2023
48,804
17 Feb 2023 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Option 4,204 $8.12 $34,136
17 Feb 2023
38,436
11 Jan 2023 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Option 4,205 $6.82 $28,678
11 Jan 2023
39,914
21 Nov 2022 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Option 1,774 $5.26 $9,331
21 Nov 2022
35,371
17 Aug 2022 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Option 1,773 $15.21 $26,967
17 Aug 2022
34,742
1 Nov 2021 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Sale 5,000 $18.07 $90,350
1 Nov 2021
32,969
2 Aug 2021 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Sale 5,000 $20.52 $102,600
2 Aug 2021
37,969
3 May 2021 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Sale 5,000 $24.84 $124,200
3 May 2021
42,969
23 Feb 2021 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Sale 15,000 $33.59 $503,850
23 Feb 2021
47,969
29 Oct 2020 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Sale 5,000 $17.48 $87,400
29 Oct 2020
62,969
20 Oct 2020 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Sale 13,986 $17.82 $249,231
20 Oct 2020
67,969
16 Oct 2020 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Sale 914 $17.00 $15,538
16 Oct 2020
81,955
5 Feb 2020 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Sale 100 $17.10 $1,710
5 Feb 2020
82,869
20 Dec 2019 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Option 2,646 $17.33 $45,855
20 Dec 2019
85,615
12 Dec 2019 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Option 4,709 $16.86 $79,394
12 Dec 2019
85,979
22 Jul 2019 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Option 7,355 $18.33 $134,817
22 Jul 2019
90,324
22 Apr 2019 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Option 7,355 $26.40 $194,172
22 Apr 2019
90,324
25 Jan 2019 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Option 5,453 $18.12 $98,808
25 Jan 2019
88,422
22 Jan 2019 Christopher Yea
CHIEF DEVELOPMENT OFFICER
Option 1,902 $16.51 $31,402
22 Jan 2019
83,569


KalVista Pharmaceuticals Inc executives and stock owners

KalVista Pharmaceuticals Inc executives and other stock owners filed with the SEC include: